Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

Ixabepilone

Intravenous Solution, intravenous (IV), 40mg/m², Day 1 every 21 days, 12 Weeks

DRUG

Paclitaxel

Intravenous Solution, IV, 80mg/m², Weekly, 12 Weeks

DRUG

Cyclophosphamide

Intravenous Solution, IV, 600mg/m², Day 1 every 21 days, 12 Weeks

DRUG

Doxorubicin

Intravenous Solution, IV, 60mg/m², Day 1 every 21 days, 12 Weeks

Trial Locations (49)

2

Local Institution, Callao

34

Local Institution, Lima

100

Local Institution, Taipei

1090

Local Institution, Vienna

1114

Local Institution, Quezon City

1417

Local Institution, Capital Federal

1425

Local Institution, Capital Federal

1650

Local Institution, Buenos Aires

5020

Local Institution, Salzburg

6000

Local Institution, Cebu City

8000

Local Institution, Davao City

10461

Albert Einstein Cancer Center, The Bronx

11217

Local Institution, Taipei

23007

Local Institution, Jaén

25198

Local Institution, Lleida

33000

Local Institution, Bordeaux

33065

Northwest Oncology & Hematology Associates, Coral Spring

33328

Florida Cancer Research Institute, Davie

33467

Medical Specialists Of Palm Beaches, Lake Worth

33612

Moffitt Cancer Center, Tampa

40138

Local Institution, Bologna

40202

University Medical Center, Inc, Louisville

40235

Local Institution, Düsseldorf

44805

Local Institution, Saint-Herblain

87131

University Of New Mexico Cancer Center, Albuquerque

91054

Local Institution, Erlangen

92262

Comprehensive Cancer Center, Palm Springs

98101

Virginia Mason Medical Center, Seattle

99204

Providence Cancer Center, Spokane

129128

Local Institution, Moscow

197022

Local Institution, Saint Petersburg

308433

Local Institution, Singapore

400012

Local Institution, Mumbai

411001

Local Institution, Pune

420029

Local Institution, Kazan'

462001

Local Institution, Bhopal

560029

Local Institution, Bangalore

632004

Local Institution, Vellore

695011

Local Institution, Trivandrum

1180AAX

Local Institution, Buenos Aires

07743

Local Institution, Jena

110 095

Local Institution, New Delhi

500 004

Local Institution, Hyderabad

LIMA 11

Local Institution, Lima

135-710

Local Institution, Seoul

135-720

Local Institution, Seoul

08035

Local Institution, Barcelona

NG5 1PB

Local Institution, Nottingham

CV22DX

Local Institution, Coventry

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY